logo

For the Inventor, By the Inventor

Berlin, Germany

Franz-Karl Maier

This inventor holds 7 USPTO granted patents. Top assignee: Schering Aktiengesellschaft. Active years: 1997-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Franz-Karl Maier. Retrieved from https://idiyas.com/inventor/franz-karl-maier

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7

% Patents Active = 100.0

Average Co-Inventor Count = 6.7

ph-index = 3

Forward Citations = 24(Granted Patents)


Company Filing History:

goldMedal7 out of 1,409 
 
Schering Aktiengesellschaft
 patents

Years Active: 1997-2001

Loading Chart...
7 patents (USPTO):Explore Patents
1. 6254850 - Metal complexes, suitable for use in diagnosis and therapy (2001-07-03),
2. 6040432 - Metal complexes, of DTPA derivatives suitable for use in diagnosis and (2000-03-21),
3. 5885548 - Multiply substituted DTPA derivatives and their metal complexes, and (1999-03-23),
4. 5853699 - Use of tetra azacycle complexes as x-ray diagnostic agents for the liver (1998-12-29),
5. 5756066 - Iodine-containing peptides (1998-05-26),
6. 5746995 - DTPA derivatives substituted in a novel way, their metal complexes, and (1998-05-05),
7. 5593660 - Cascade polymers with iodoaromatic compounds (1997-01-14),

Title: Franz-Karl Maier: Innovator in Metal Complexes

Introduction

Franz-Karl Maier is a prominent inventor based in Berlin, Germany. He has made significant contributions to the field of chemistry, particularly in the development of metal complexes for medical applications. With a total of seven patents to his name, Maier's work has had a substantial impact on diagnostic and therapeutic practices.

Latest Patents

Maier's latest patents include innovative metal complexes suitable for use in diagnosis and therapy. One of his notable inventions relates to diethylenetriaminepentaacetic acid derivatives, their complexes, and complex salts. These compounds contain elements with atomic numbers ranging from 20 to 32, 39 to 51, or 57 to 83. His patents also cover pharmaceutical agents that utilize these compounds as contrast media and antidotes, along with the processes for their production.

Career Highlights

Franz-Karl Maier has built a successful career at Schering Aktiengesellschaft, a leading pharmaceutical company. His expertise in metal complexes has positioned him as a key figure in the development of new diagnostic tools and therapeutic agents. His work continues to influence the medical field, enhancing the effectiveness of treatments and diagnostics.

Collaborations

Throughout his career, Maier has collaborated with notable colleagues, including Werner Krause and Michael Bauer. These partnerships have fostered innovation and have contributed to the advancement of their shared research interests.

Conclusion

Franz-Karl Maier's contributions to the field of metal complexes have established him as a significant inventor in the medical chemistry landscape. His patents reflect a commitment to improving diagnostic and therapeutic methods, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…